Vaccine Manufacturing – how will supply chain complexity effect a distributed vaccine manufacturing network?
As of October 2021, 6-7 billion doses of COVID-19 vaccines [...]
Sustainability Interview – Life Cycle Assessment
Today we have a special guest – Bill Flanagan to [...]
UK biomanufacturing team to spearhead development of advanced controls to accelerate drug and vaccine manufacturing
A UK-based consortium consisting of BiologIC Technologies, Biopharm Services, CPI, [...]
Plasmid DNA, mRNA and Viral Vectors – the Building Blocks of Cell and Gene Therapy Processing
The growing pipeline of cell and gene therapy therapies has [...]
Biopharm Services Interview McMaster University Part 1
Biopharm Services and McMaster University is kicking off the collaboration [...]
Interview with Javier Lozano from SDD™
Q What is your name and your involvement to SDD™?A [...]
Antibody Drug Conjugates aren’t “too expensive” – how can the costs of manufacture be monitored and improved?
The historical development of antibody drug conjugates is a well [...]
